Last reviewed · How we verify

NCT06245226

Assessment of Posture, Balance, Gait Disorders in Patients With Fibromyalgia

Status unknown Last updated 7 February 2024
What this trial tests

trial in Fibromyalgia in 100 participants. Status unknown.

Timeline
15 October 2023
Primary endpoint
15 March 2024
1 April 2024

Quick facts

Lead sponsorAnkara City Hospital Bilkent
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date15 October 2023
Primary completion15 March 2024
Estimated completion1 April 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 18 to 65, female only, with Fibromyalgia or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to determine the posture, balance and gait disorders objectively in patients with fibromyalgia (FM) and to investigate their relationships with disease-related parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06245226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing